A mathematical model for the design of fibrin microcapsules with skin cells
Transcript of A mathematical model for the design of fibrin microcapsules with skin cells
ORIGINAL PAPER
A mathematical model for the design of fibrin microcapsuleswith skin cells
Cristian A. Acevedo Æ Caroline Weinstein-Oppenheimer Æ Donald I. Brown ÆHolger Huebner Æ Rainer Buchholz Æ Manuel E. Young
Received: 1 May 2008 / Accepted: 22 July 2008 / Published online: 13 August 2008
� Springer-Verlag 2008
Abstract The use of fibrin in tissue engineering has
greatly increased over the last 10 years. The aim of this
research was to develop a mathematical model to relate the
microcapsule-size and cell-load to growth and oxygen
depletion. Keratinocytes were isolated from rat skins and
microencapsulated dropping fibrinogen and thrombin
solutions. The cell growth was measured with MTT-assay
and confirmed using histochemical technique. The oxygen
was evaluated using a Clark sensor. It was found that Fick–
Monod model explained the cell growth for the first 48 h,
but overestimated the same thereafter. It was necessary to
add a logistic equation to reach valid results. In relation to
the preferred implant alternative, when considering large
initial cell loads, the possibility to implant small loads of
fast-growing cells arises from the simulations. In relation to
the microcapsule size, it was found that a critical diameter
could be established from which cell growth velocity is
about the same.
Keywords Fibrin � Microencapsulation � Keratinocytes �Logistic equation � Oxygen diffusion
List of symbols
C oxygen concentration
Deff effective diffusivity
K Monod constant
k logistic parameter
KLa oxygen transfer coefficient
PR proliferation rate
q respiration rate
r radius of cell cluster
R radius of microcapsule
t time
V volume of cell cluster
X cell concentration
l specific growth rate
Subscripts
AP apparent
EQ equilibrium
M maximum
O initial
SAT saturation
Introduction
The pioneering work of James Rheinwald and Howard
Green allowed for the successful culture of keratinocytes
utilizing a substrate of irradiated 3T3 fibroblast feeder layers
[1]. This became the basis for constructing therapeutic sys-
tems to be applied in the treatment of burned patients. This
3T3 feeder layer culture takes too long to cultivate enough
keratinocytes to built implants large enough to treat large
areas of damaged skin, during which period, the condition of
C. A. Acevedo (&) � M. E. Young
Biotechnology Center, Universidad Tecnica Federico Santa
Marıa, Av. Espana 1680, Valparaıso, Chile
e-mail: [email protected]
C. Weinstein-Oppenheimer
Departamento de Bioquımica, Facultad de Farmacia,
Universidad de Valparaıso, Av. Gran Bretana 1093, Valparaıso,
Chile
D. I. Brown
Departamento de Biologıa y Ciencias Ambientales, Facultad de
Ciencias, Universidad de Valparaıso, Av. Gran Bretana 1111,
Valparaıso, Chile
H. Huebner � R. Buchholz
Department of Bioprocess Engineering,
Friedrich-Alexander University of Erlangen-Nuremberg,
Paul Gordan Str. 3, 91052 Erlangen, Germany
123
Bioprocess Biosyst Eng (2009) 32:341–351
DOI 10.1007/s00449-008-0253-1
the burned patient often deteriorated beyond recovery [2].
However, the repair of damaged human skin can be
improved greatly by organizing the skin cells [3], such as
using the cells when they are immobilized in the matrix, to
construct the scaffolds. The most frequent matrices are those
made out of alginate [4], even though chitosan, glycosami-
noglycans, polyacrylates and poly (vinyl alcohol) are also
used [5]. Fibrin has also being included as a possible
material for cell support, being a natural polymer with a
well-known function related to cell differentiation. Fibrin
microcapsules may be easily obtained by thrombin cata-
lyzed polymerization of fibrinogen.
The application of a commercial fibrin gel containing
cultured keratinocytes was first reported by Hunyadi et al.
[6]. Fibrin gels have since been used as a dermal matrix
containing keratinocytes [7]. The use of commercial Fibrin
in tissue engineering practices has increased over the last
10 years [9–11]. Fibrin has been proposed as a delivery
matrix in seeding urothelial cells for urethral reconstruction
[12], and in the form of microcapsules as effective carriers
to support the bone and cartilage-forming potential of
different types of cells [13]. It has also been tested as a
vehicle to deliver viable cells to infarcted myocardium,
which increases cell viability [10, 11].
Its use as a polymeric support for the transplant of
human skin cells has also been reported [2]. The first in
vitro studies were done in rat models. The results were
successful, showing an improvement in the proliferation,
migration and differentiation of the cells compared to
keratinocytes cultured in traditional cell culture flasks [8].
It was later reported that keratinocyte culture in fibrin,
maintains the cells in a proliferative state and improves the
grafts containing these cells [14].
To successfully grow skin cells, it is important to pre-
vent uncontrolled cell growth and overcrowding of cells
within the immobilization device, a situation which would
lead to nutrient and oxygen depletion resulting in cell death
[15]. Oxygen and nutrient supply to cells inside a micro-
capsule mainly depend on mass diffusion. In large
microcapsules, diffusion gradients are formed so that the
cells in the center are not liable to get sufficient nutrients to
support growth. Conversely, the rate of waste removal from
the center is insufficient and thus the cells eventually die
[16]. Oxygen transportation is normally considered as the
main limiting factor for nutrient exchange in cells, such as
hepatocytes [16], chondrocytes [17], hybridoma [18],
fibroblasts [19], mesenchymal stem cells [20] and many
other cells. In implying that fact, hypoxia is being reported
as an important mechanism for regulation of gene expres-
sion in eukaryotic cells [21–23]. In particular for
keratinocytes, anoxia conditions alter cell morphology and
seem to delay senescence, allowing for more passages in
surface growth [24].
All of these conditions, which are related to the kinetic
growth of keratinocytes during in vitro cultures, indicate a
strong dependence on oxygen concentration. The cell
growth in flasks is characterized by a thin liquid layer with
nutrients designed to contain all excess requirements, and
the oxygen present in the environment is sometimes reg-
ulated to contain a lower oxygen concentration from that in
the air, thereby indirectly controlling the maximum load of
oxygen that a solution might have. In addition, the cells
attached to the flask in monolayers have easy access to
dissolved oxygen. When keratinocytes are encapsulated a
new barrier to oxygen availability is created, because the
liquid phase is separated from the cells generating an
oxygen profile inside the microcapsule. This becomes
critical for larger microcapsule diameters.
There are many studies available which are trying to
predict nutrient behavior in solid matrices by applying
mathematical modeling [16–18, 20, 25]. All theoretical
approaches consider oxygen diffusion explained by Fick’s
law, and oxygen consumption kinetics linked to the Monod’s
equation through a yield parameter. In our work, we
hypothesized that the proliferation rate in the microencap-
sulated cells cannot be fully explained by the Monod model
in its simplest version which requires additional complexity.
We proposed to apply a modified form of the model by
including an additional parameter given by a logistic
equation. The aim of this research was to develop and
validate such a mathematical model for keratinocyte
growth in encapsulated fibrin beads. The developed model
will provide guidance in designing the system intended for
tissue engineering purposes.
Materials and methods
Cell isolation and culture
The primary cell culture was obtained from rats (strain cpr
100). They were anesthetized with ketamine/xilacine (5 mg
and 2 mg per 100 g of body weight, respectively), shaved,
and disinfected with a povidone-iodine solution. A biopsy
of 1 cm2 was taken from the dorsal area of the animal.
Animals were treated according to the Guide for the Care
and Use of Laboratory Animals (National Academy of
Sciences, USA).
The technique utilized for isolation and culture of skin
cells was adapted from previously published reports [26].
Briefly, the biopsy was washed three times with phosphate
buffer saline, 0.1 M, pH 7.4 (PBS) containing penicillin
(100 U/mL), streptomycin (100 lg/mL) and amphotericin
B (25 lg/mL). The visible fat was mechanically removed.
The clean biopsy was incubated overnight at 48C in trypsin-
EDTA (0.05%–0.53 mM).
342 Bioprocess Biosyst Eng (2009) 32:341–351
123
The epidermis layer was removed, sliced into 1-mm
pieces and incubated for 1 h in trypsin-EDTA (0.05%–
0.53 mM). The recovered cells were filtered through sterile
gauze and cultured in Defined Keratinocyte Media. All
reagents were purchased from Gibco-Invitrogen.
Cells microencapsulated in fibrin beads
Cells were microencapsulated using a coaxial microen-
capsulation apparatus [18], with fibrinogen and thrombin
solutions. Fibrinogen solution (80 mg-lyophilized/mL;
lyophilized: 78% protein, 87% clottable protein; Sigma-
Aldrich) and thrombin solution (130 units-NIH/mL,
80 mM CaCl2; MP ICN-Biomedicals) carrying the cells
[12], were coagulated forming a drop on oil phase (tri-
glyceride mixture of capric/caprylic acid) [27].
Evaluation of oxygen consumption by keratinocytes
Free cells (4 9 106) were introduced in a batch micro-
bioreactor with 5 mL of media at 37 8C. The concentration
of dissolved oxygen was measured using a Clark type
polarographic sensor (WTW Multiline P4) for 2 h. The
correction, due to sensor response time delay was taken
into account as described by Jorjani and Ozturk [28]. The
resulting data was modeled, taking into consideration, the
fact that the change in oxygen concentration increases by
mass transport and is consumed by the cells, as follows:
oC
ot¼ KLaðCSAT � CÞ � X qM
C
K þ C
� �
This equation was solved with numerical solutions and
fit with experimental values using minimum square
criterion in Frontline Solver Software. The parameter KLa
was determined under steady-state conditions characterized
by no time change in oxygen concentration.
Viable cell count
The number of viable cells was evaluated by MTT-assay,
which measures the ability of mitochondrial dehydroge-
nase enzymes to convert the soluble yellow MTT salt (3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide) into insoluble purple formazan salt [29, 30].
Microcapsules were incubated with MTT solution
and Defined Keratinocyte Medium (Gibco-Invitrogen) in
the proportion of 1:4, for 4 h at 37 8C. MTT solution
(Sigma–Aldrich) was prepared at 0.5% in PBS. Then, the
microcapsules were disaggregated with trypsin 0.5%
(Gibco-Invitrogen) at 37 8C. Lysis buffer (SDS 3%w/v and
HCl 40 mM, in isopropanol) with ultrasounds (15 min)
were used to solubilize formazan.
The factor used to estimate viable biomass was the total
formazan production after reaching a plateau level (end
point). To be certain that absorbance proportional to cell
number is measured instead of enzyme activity, previous
experiments were performed with known number of
immobilized keratinocytes confirming that before 4 h the
plateau is reached indicating cessation of enzyme activity.
For each experiment, a calibration curve was produced
from known microencapsulated viable cell previously
counted in a Neubauer chamber and assayed by MTT. Cells
before microencapsulation were stained with trypan-blue
solution (Gibco-Invitrogen) in order to recognize viable
and unviable cells.
Histochemistry and immuno-histochemistry
The cells microencapsulated were fixed in Bouin’s solution
for 24 h, dehydrated in alcohol solutions (ethanol 70%,
ethanol 95% and butanol), and embedded in Paraplast Plus
(Sigma–Aldrich). Serial sections of 5 lm thickness were
cut in a microtome, mounted on microscope slides,
hydrated and stained or immunostained.
To perform the histochemistry analysis, the Arteta tri-
chrome stain was applied, using Harris–hematoxylin
solution for 75 s (the nuclei became dark blue). Afterward,
erythrosine-B/orange-G (0.5/0.5%) was used for 30 min (to
stain the cytoplasm red) and finally aniline-blue (1%) for
75 s (to stain the extracellular matrix or collagen light-
blue). All dyes were obtained from Sigma–Aldrich.
Keratinocytes were identified by immunostaining using
an AE1/AE3 monoclonal antibody for cytokeratin (Dako-
Cytomation). To recognize possible fibroblast cross-
contamination, another set of slides was incubated with the
polyclonal antibody for vimentin (c-20): sc-7557 (Santa
Cruz Biotechnology). The amplification was developed
with the immuno-peroxidase technique using a commercial
kit of avidin-biotin-peroxidase complex (ABC) (Vectastain-
ABC, Vector) and DAB (Sigma–Aldrich) as chromogen
which produces a brown color in positive detection.
Results
Histochemistry and inmunohistochemistry
The histological sections from microcapsules with cells
stained with Arteta thrichrome show that the fibrin is
present in a heterogeneous matrix that is mainly stained
with the aniline blue and red with erythrosine in the free
borders (Fig. 1a–d). In this matrix there are spaces where
the cells are located (Fig. 1a–e). In the first 3 days,
individual cells observed (Fig. 1a–c), among those mitotic
Bioprocess Biosyst Eng (2009) 32:341–351 343
123
figures are frequent (Fig. 1b; metaphase in polar view). In
Fig. 1d a pair of cells is observed, with their characteristic
slightly ovoid nuclei with a very marked nucleole. Over
longer periods, cells joined in clusters appear in the
spaces inside the fibrin (Fig. 1e, f). In these groups typical
mitotic figures are common (Fig. 1f; metaphase in polar
view).
In the serial sections of microcapsules, in this case with
clusters of cells (Fig. 1g), a clear positive reaction with the
antibody to anti-cytokeratin is present (Fig. 1h). On the
contrary, there is not evident reaction with the anti-
vimentin antibody (Fig. 1i). Therefore, the presence of
keratinocytes without fibroblasts contamination is
indicated.
Simple model: diffusion and Monod
From the kinetics experiments with microencapsulated
cells, increasing cell mass was observed with the cells
arranging in aggregates inside the microcapsule. To
establish a relationship between the observed viable cells
increase and oxygen availability, a diffusion model based
on Fick’s behavior for oxygen was used which explains
oxygen transportation, only in terms of the concentration
Fig. 1 Histology and immuno-
histochemistry of
microencapsulated cells.
Histology of cells
microencapsulated in fibrin
stained with Arteta thrichrome
stain. a One cell in a zone of
homogeneous fibrin stained
with aniline blue (1 h after
microencapsulation). b One cell
in metaphase (polar view) in a
space near fibrin stained with
erythrosin (48 h after
microencapsulation). c Three
cells in a fibrin fold (24 h after
microencapsulation).
d A couple of cells between
fibrin matrix (48 h after
microencapsulation). e Clusters
of cells in spaces (arrowheadsand arrow) inside the fibrin
(96 h after microencapsulation).
f A high magnification view of a
cluster of cells from e (arrow),
where there is a cell in
metaphase (polar view).
Immuno-histochemistry of a
cluster of cells growing in fibrin.
g Control section stained with
Arteta thrichrome stain.
h Consecutive sections with
strong positive immuno-
localization for cytokeratin in
the cytoplasm of cells; it is
evident that nuclei are negative
(white round spaces).
i Consecutive section showing
negative reaction for vimentin
immunolocalization
344 Bioprocess Biosyst Eng (2009) 32:341–351
123
gradient inside the microcapsule, assuming initial homo-
geneous distribution of cells [25]:
oC
ot¼ Deff
o2C
oR2þ 2
R
oC
oR
� �� qM
C
K þ C
� �X
The parameters K and qM were evaluated by using
respirometric experiments with free cells—without diffusion
limitations—as previously described in methods, where
4 9 106 cells were introduced in a micro-reactor containing
5 mL of cell culture medium at 37 8C and oxygen
consumption monitored over a short period of time with a
polarographic Clark sensor. Figure 2 shows the experimental
data together with the adjusted values. A good agreement was
found using the non-linear methods correlation. The specific
rate of oxygen consumption obtained for the rat
keratinocyctes was similar to that reported for other animal
cells as seen in Table 1, with maximum oxygen demand
qM of 9.7 9 10-17 mol/cell s; this result is in the order
of magnitude of other cells like fibroblasts (4–7 9 10-17),
stem cells (1–3 9 10-17), hybridomas (6 9 10-17) and
monocytes (1–18 9 10-17) [31].
The adjusted ‘‘K’’ value was found to be 0.2 mg/L; this
value is very close to the 0.19 mg/L reported for chon-
drocytes [32].
To include the effect of cell growth in the microen-
capsulated experiment (qX/qt = lX), Monod’s equation
was applied to the specific growth as follows:
l ¼ lM
C
K þ C
The short time experiments performed to determine the
duplication time using the MTT proliferation assay (as
described in the experimental section) in triplicate, resulted
in a duplication time of 28 h, close to 1.2 days. Therefore,
in lM equal to 0.6 day-1 or 6.88 9 10-6 s-1 (l = 0.693/
duplication-time). For cell growth in skin, the duplication
time of keratinocytes is 300 h, but it is being reported that
for psoriasis: it is approximately 30 h [33]. In cell cultures
of human keratinocytes, a duplication time of 20 h has
been reported [24].
With all these parameters having already been evalu-
ated, oxygen concentration and cell growth in the
microcapsule can be predicted using the following
boundary conditions: symmetry in the center of the sphere
(microcapsule) and mass transfer resistance at the micro-
capsule-bulk interface evaluated considering Sherwood
Number equal 2, for static sphere [34]. The oxygen diffu-
sion coefficient was estimated as a value in water
(2.4 9 10-5 cm/s2 at 25 8C) [34], corrected for tempera-
ture and a hydrogel environment [25]:
Deff ¼ 2:4 � 10�5ðcm=s2Þ 310�K
298�K
� �ðe�4�0:04Þ
¼ 2:1� 10�5ðcm=s2Þ
For microcapsules 5 mm in diameter with initial cell
concentration of 9 9 105 cells/mL, Fig. 3 shows that the
model explains the cell number data for the first 48 h very
well, overestimating thereafter. A possible explanation for
the decrease in growth [16] is the development of local
extreme hypoxia inside the observed clusters, which appear
as the cells grow in the beads (Fig. 1e, f). This situation
was not accounted for by the mathematical model where
cells were assumed to be well dispersed individuals inside
the microcapsule. Therefore, a modification is necessary if
the histological observations are to be taken into account,
which leads toward the application of a logistic equation.
Logistic equation to predict cell growth
From histological observations, a sample of which are
presented in Fig. 1a, c show that at the beginning of the
process, the microcapsules contain individual cells with
well-delimited nucleus and cytoplasm. At day 2, cells in
division are observed (Fig. 1b, d), and from day 3 the
dividing cells form clusters of many individuals.
Fig. 2 Respirometric experiment. The cells (4 9 106) were intro-
duced in a batch micro-reactor with 5 mL of cell culture medium at
37 8C. Oxygen consumption was monitored with a polarographic
Clark sensor. The experimental data were fitted to Monod’s equation
using minimum square criterion. The blank-experiment without cells
did not show a significant oxidation into the medium (p [ 0.05)
Table 1 Values of oxygen uptake rate in mammalian cells
Cell type Oxygen uptake
rate (mol/cell s)
Rat hepatocytes [42] 2.0 9 10-16
Rat keratinocytes (our data) 9.7 9 10-17
Hybridoma [18] 6.0 9 10-17
Chinese hamster ovary [42] 8.3 9 10-18
Human embryonic lung fibroblasts [42] 2.5 9 10-18
Bovine chondrocytes [17] 1.9 9 10-18
Bioprocess Biosyst Eng (2009) 32:341–351 345
123
The cells aggregated in spheroids exhibit extensive cell–
cell contacts and tight junctions [35]. Thus, cell aggrega-
tion is assumed to be an important factor in tissue culture
processes. From the perspective of mass transfer, however,
cell aggregation in culture generates an additional resis-
tance effect on oxygen transportation implying local
extreme hypoxia at the center, thereby affecting cell via-
bility and function [16]. In our experiments, these effects
appear after 48 h when cluster formation is evident.
To include this additional resistance to oxygen diffusion
transport in the equations, the use of a logistic equation is
proposed which takes cell growth in aggregates into
account. Following Glicklis et al. [16], the logistic equation
assumes that initially, cluster radius increases following a
first order kinetics which is balanced by a second order
term thereby reaching a maximum radius, rM where growth
stops.
or
ot¼ kr 1� r
rM
� �same
o
ot
r
rM
� �¼ k
r
rM
1� r
rM
� �
Furthermore, assuming that cluster radius is related to
cell mass: X, proportional to r3, the kinetic equation
becomes:
oX
ot¼ 3k 1� X
XM
� �1=3 !
X same
oPR
ot¼ 3k 1� PR
PRM
� �1=3 !
PR
Rearranging in terms can be made by including the
proliferation rate PR concept (PR = X/X0), which reaches
a maximum PRM = XM/X0.
Experimental data were fitted to the modified form of
the logistic equation assuming that initially all cells are
individual, and each individual cell produces one cluster,
all well distributed inside the microcapsule. In Fig. 4, it is
shown that the growth data can be explained by the logistic
model where the k logistic parameter is 1.28 9 10-5 (s-1),
with a maximum proliferation rate PRM of 2.9.
Modified model: diffusion, Monod and logistic
Coupling Monod’s equation with the logistic model, we
produce a new specific growth rate expression taking into
account both, cell growth in cluster and oxygen limitation
in the fibrin microcapsules:
l ¼ lM;AP
C
K þ C
where the apparent specific rate growth lM,ap includes the
parameters of the logistic equation:
lM;AP ¼ 3k 1� PR
PRM
� �1=3 !
same
lM;AP ¼ 3k 1� X=Xo
PRM
� �1=3 !
Figure 5 shows the oxygen concentration in the fibrin
matrix and the cell concentration in time.
Additional kinetic data for sphere-microcapsules 3 and
5 mm in diameter, and initial concentration between
8 9 104 and 8 9 105 (cells/mL) were simulated using the
same adjusted parameters presented in Table 2. Figure 6
shows simulated and real data. It is observed that the
simulations adjust well to the experimental values. When
the bisector statistical criterion was used, a unit slope was
Fig. 3 Simple model. Experimental data and simulated values of cell
growth were obtained with fibrin microcapsules of 5 mm diameter
and initial cell concentration of 9 9 105 cells/mL. For the first 48 h,
the error between experimental and simulated data with the simple
model was not significant (p [ 0.05). The oxygen concentrations on
the surface and center of microcapsule were simulated with the simple
model (oxygen concentration in the center of the microcapsules is
asymptotic to zero)
Fig. 4 Logistic equation. Experimental data of cell growth were
obtained microencapsulated keratinocytes in fibrin at initial concen-
tration of 1 9 105cells/mL. The logistic equation was used to fit
experimental data (the mathematical correlation was significant,
p \ 0.05)
346 Bioprocess Biosyst Eng (2009) 32:341–351
123
obtained (p [ 0.05) with zero offset (p [ 0.05), thereby
pointing toward the validity of the proposed model.
In Table 2, the simple and modified models are pre-
sented in a comprehensive manner, showing the common
characteristics and highlighting the differences.
Design of microcapsules
With this modified model (diffusion, Monod and logistic), it
is now possible to analyze the effect of diameter and initial
concentration of cells on cell growth over time. Figure 7
shows the simulated kinetic until steady state is reached in
3 days. It is clear that only upto 105 cells/mL initial con-
centration the size of a microcapsule is not an important
parameter, thereby indicating that all nutrients diffuse
freely and all limitation resides in the aggregates. As the
initial cell concentration increases above106 cells/mL, the
maximum attainable concentration is lower for larger mi-
crocapsules suggesting nutrient limitation by diffusion. This
effect in terms of proliferation rate (PR) can be seen in
Fig. 8; microcapsules including 105 cells/mL reach the
maximum PR (2.9) for all microcapsule diameters, but
those including 107 cells/mL approach 2.9 PR value near to
1 mm with lower PR for larger microcapsules.
Fig. 5 Simple and modified model. Experimental data and simulated
values of cell concentration were obtained with fibrin microcapsules
of 5 mm diameter and initial cell concentration of 9 9 105 cells/mL.
The prediction error of simple model is not significant only in the first
48 h (p [ 0.05). The prediction error of modified model is not
significant in whole kinetic (p [ 0.05)
Table 2 Mathematics models
Fig. 6 Bisector criterion to validate the modified model. Four
experimental kinetics (four sampling-times per experiments) were
used to develop the curves (regression and confidence interval). The
size and initial cell concentration in the microcapsule were: First
experiment, 3 mm and 8 9 104 cell/mL; Second experiment, 3 mm
and 3 9 105 cell/mL; Third experiment, 5 mm and 7 9 105 cell/mL;
and Fourth experiment, 5 mm and 8 9 105 cell/mL
Bioprocess Biosyst Eng (2009) 32:341–351 347
123
Discussion
Microencapsulated keratinocytes behavior
The growth of keratinocytes microencapsulated in fibrin
matrix of different sizes was studied in relation to oxygen
consumption taken as the limiting substrate. Keratinocytes
were obtained from epidermis, mechanically separated from
other skin layers after trypsin incubation of a rat skin biopsy.
The pre-confluent cells in culture were recovered and
encapsulated in fibrin, following the procedure described
earlier. Histological sections showed healthy cells lodged in
sites inside the heterogeneous fibrin matrix. The cells with
their characteristic round morphology are in active prolif-
eration, as revealed by the presence of mitotic figures, until
they organize in three-dimensional compact clusters. At this
stage they were immuno-stained with anti-Cytokeratin, clon
AE1/AE3, which reacts with most cytokeratins [36, 37]
allowing positive identification of keratinocytes inside the
microcapsule. Moreover, when histological sections were
immuno-stained with polyclonal anti-Vimentin, looking for
the presence of fibroblasts, scarce reaction was verified,
thereby indicating a predominant population of keratino-
cytes with meaningless presence of fibroblasts.
During the initial 2 days, sustained cell growth was
verified by MTT assay and histochemical observations.
After this, the MTT analysis shows a decrease in cell
activity which could be attributed to a reduction in the cell
growth rate. This reduction in cell activity concurs with
evidence of growth in three-dimensional clusters observed
inside the microcapsule, which may explain the change in
kinetic behavior related to local nutrient depletion inside
the clusters. At this stage, the observed keratinocytes
exhibit a morphology which is different from the one
usually observed when growth occurs in flasks. This
change in morphology was also reported by Weiss et al.
[38] for keratinocytes cultured in plastic flasks with and
without fibrin coating where the usual polyedric shape
observed in monolayers and developed in plastic flasks
turned into a rounded shape which duplicates in three
dimensions forming cord-like structures. In our case, the
round-shaped cells predominated, arranging in spherical
three-dimensional compact clusters.
Cells growing inside the microcapsule obtain oxygen
from the growth medium by a diffusion mechanism
through the fibrin matrix. Depending on the location with
respect to the microcapsule, they are exposed to different
degrees of hypoxia. Improved proliferation of skin cells
under hypoxia has been reported [19, 24], which may
explain the initial sustained growth during the first 2 days.
The observed compact clusters of cells, leaving no apparent
interstitial space, suggest that oxygen and most probable
nutrient starvation for the cells inside the cluster is taking
place, with the adverse effect for the cell proliferation
observed after day 2. An association could be made with
quiescent cell growth when reaching confluence in con-
ventional cell culture flasks. Even though the cells inside
the microcapsule were far from reaching confluence, they
behave in a similar fashion with regard to oxygen.
Commencing day 4, during the course of the experi-
ment, the microcapsule showed the first signs of
fibrynolysis starting to disintegrate. We chose not to use
that data, because cell growth could be affected by other
phenomenon besides oxygen diffusion. This phenomenon
has been discussed by other authors: for commercial hard
fibrins, where degradation times of 15 days for culture of
keratinocytes have been reported [39], and degradation
times less to 21 days in rat grafts [40]. Other authors, using
the same protocol, reported a different fibrynolysis time
Fig. 7 Simulated growth kinetics with the modified model. Three
initial cell concentrations in fibrin microcapsules were used: 105, 106
and 107 (cell/mL), and three sizes of microcapsule were used: 1, 3
and 5 mm diameter
Fig. 8 Simulated values using the modified model for microcapsule
design. Three initial cell concentrations in fibrin microcapsules were
used: 105, 106 and 107 (cell/mL). Proliferation rate (PR) was defined
as the rate between viable cell number after 3 days and initial viable
cell number
348 Bioprocess Biosyst Eng (2009) 32:341–351
123
depending on the use of primary keratinocytes or estab-
lished cell lines [27].
Model and design of microcapsules
It was found that the simple Fick’s diffusion model toge-
ther with a Monod’s growth kinetics well represents the
data of cell growth associated with predicted values for
oxygen concentration in the microcapsule over the first
2 days. For longer periods, this simple model fails in the
interpretation of data since growth starts to decrease. In
Fig. 3, it is predicted that during the first 24 h, oxygen
concentration in the center of the microcapsule decreases to
about 0.4 mg/L, the same as the concentration in a solution
in equilibrium with air at 1% oxygen concentration, and
there is evidence in literature that in this condition, kerat-
inocytes are viable and proliferate [24] (our data shows
cells to be growing fast). At 48 h, Fig. 3 shows oxygen
depletion in the center of the microcapsule but in the
largest sections of it, concentration is well above 0.4 mg/L.
Nevertheless, by this time, growth starts declining. In 72 h
the oxygen concentration in the microcapsule surface
reaches 0.4 mg/L and cell growth is observed to decline
fast; however, it is also observed that clusters of cell col-
onies appear, including a situation of additional oxygen
limitation for the cells inside the cluster creating micro-
environments not taken into account by the model, where a
major assumption was the homogeneous distribution of
single cells inside the microcapsule. The effect of cluster
formation on cell growth was included into the model
making use of a logistic type equation relating mass cell
increase with increase in the radius of the cluster.
The logistic equation (also known as the Verhulst model
or logistic growth curve) is a model of population growth
first published by P.F. Verhulst in the nineteenth century
[41], who suggested that the rate at which any population
increases may reach a limit. Logistic model therefore plays
two biological processes in opposition: reproduction and
restriction. Both processes depend on population numbers
(or density). The rate of both processes is explained by the
mass-action law with coefficients: ‘‘k’’ for the first order
kinetics (kr), modeling reproduction and ‘‘k/rM’’ for the
second order kinetics (kr2/rM) modeling restriction.
Our data show that proliferation dominates over the first
2 days when the first order kinetics is the larger term due to
small radius size. Thereafter, competition for space,
nutrients and oxygen causing restriction hinder the prolif-
eration process, when the second order term becomes the
same order of magnitude as the first order kinetics due to a
larger radius with cluster formation, reaching steady state
when the population has increased by approximately three
times and both terms are equal. The presence of a first
order kinetics is clear; nevertheless the occurrence of the
second order kinetics could be derived from several factors.
Competition for space is associated to increase in volume
and the rate of change in volume of a cluster assumed
spherical with respect to the radius (qV/qr) is a second
order function of the radius (qV/qr = 4pr2), which implies
that if oxygen availability affects consumption due to the
size of the colony, then the relationship should be
quadratic.
On the other hand, from the simulation of growth lim-
itation by oxygen concentration, it is possible to conclude
that at cell loads of 105 cell/mL, the effect of the micro-
capsule size is not significant, and that during the first day,
all cultures show exponential cell growth. In addition, the
microcapsule diameter of 1 mm always shows exponential
cell growth. The cell load of 105 cell/mL and size of 1 mm
are data of special consideration, because they could be
critical parameters to design microcapsules without diffu-
sion limitation (see Figs. 7, 8). For instance, it may be
predicted that low cell loads immobilized in small micro-
capsules for 1 day would be the optimum for implants
because the cells are in the highest proliferative stage under
these conditions. It is important to point out that this cri-
terion is not universal, but the methodology to establish the
best condition for cell growth on a particular scaffold may
be applied to other tissue engineering systems.
Conclusions
In the field of tissue engineering, it is important to choose
the optimum time for performing the implant. For that, it is
necessary to estimate the viable cell density and predict the
proper time for the implant-surgery. If a traditional model
is used as a predictor—based solely on a Diffusion-Monod
approach—the cell growth can be overestimated because
the cells grow forming clusters and the assumption of
disperse growth is invalid. We concluded that there is a
critical time when it is possible to use a simple model. In
our case, 48 h is the limit where fast growth occurs and an
arrest due to oxygen limitation takes place.
Another important issue that the proposed model revealed
is related to initial cell concentration, demonstrating that for
low cell loads, the microcapsule size is not relevant. This is
not the case for high cell loads, where significant differences
in growth were detected indicating the existence of a critical
cell load. In our case the critical load is 105 cells/mL as the
cells grew in all microcapsule sizes. This information could
be used to develop a useful criterion for tissue engineering, as
the preferred strategy is large seed populations used to insure
a successful implant. Our simulations show that low cell
loads have a period of fast growth not observed when large
populations are applied, making allowance for an alternative
approach in implant design.
Bioprocess Biosyst Eng (2009) 32:341–351 349
123
On the other hand, when the microcapsule size is very
small, the cells grow fast at low and high initial concen-
trations, indicating the existence of a critical diameter. The
critical load and critical diameter are data of special con-
sideration, because they could be important parameters to
design skin microcapsules without diffusion limitations. In
our case, these parameters are 105 cell/mL and of 1 mm.
This information could be used to develop a useful crite-
rion to design cell growth in a three-dimensional matrix.
Acknowledgment The authors thank CONICYT from Chile by:
FONDEF Grant (# DO2I1009) and Doctoral Scholarship for Cristian
Acevedo (# D-21050588).
References
1. Rheinwald JG, Green H (1975) Serial cultivation of strains of
human epidermal keratinocytes: the formation of keratinizing
colonies from single cells. Cell 6:334–344
2. Currie L, Sharpe J, Marin R (2001) The use of fibrin glue in skin
grafts and tissue-engineering skin replacement: a review. Plast
Reconstr Surg 108:1713–1726
3. Harding SI, Underwood S, Brown RA, Dunnill P (2000) Assess-
ment of cell alignment by fibronectin multi-fibre cables capable of
large scale production. Biopro Biosyst Eng 22:159–164
4. Acevedo C, Sanchez E, Reyes JG, Young ME (2007) Volatile
organic compounds produced by human skin cells. Biol Res
40:347–355
5. Uludag H, De Vos P, Tresco PA (2000) Technology of mam-
malian cell encapsulation. Adv Drug Deliv Rev 42:26–64
6. Hunyadi J, Farkas B, Bertenyi C, Olah J, Dobozy A (1998)
Keratinocyte grafting: a new means of transplantation for full-
thickness wounds. J Dermatol Surg Oncol 14:75–78
7. Meana A, Iglesias J, Del Rio M, Larcher F, Madrigal B, Fresno
MF, Martin C, San Roman F, Tevar F (1998) Large surface of
cultured human epithelium obtained on a dermal matrix based on
live fibroblast-containing fibrin gels. Burns 24:621–630
8. Horch RE, Bannasch H, Kopp J, Andree C, Stark GB (1998)
Single-cell suspensions of cultured human keratinocytes in fibrin-
glue reconstitute the epidermis. Cell Transplant 7:309–317
9. Geer DJ, Swartz BS, Andreadis ST (2002) Fibrin promotes
migration in a three-dimensional in vitro model of wound
regeneration. Tissue Eng 8:787–798
10. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ (2004) Fibrin
glue and skeletal myoblasts in a fibrin scaffold preserve cardiac
function after myocardial infarction. Tissue Eng 10:403–409
11. Zhang GE, Wang X, Wang Z, Zhang J, Suggs L (1996) A
PEGylated fibrin patch for mesenchymal stem cell delivery.
Tissue Eng 12:9–19
12. Bach AD, Bannasch H, Galla TJ, Bittner KM, Stark GB (2001)
Fibrin glue as matrix for cultured autologous urothelial cells in
urethral reconstruction. Tissue Eng 7:45–53
13. Perka C, Arnold U, Spitzer RS, Lindenhayn K (2001) The use of
fibrin beads for tissue engineering and subsequential transplan-
tation. Tissue Eng 7:359–361
14. Pellegrini G, Ranno R, Stracuzzi G, Bondanza S, Guerra L,
Zambruno G, Micali G, Deluca M (1999) The control of epi-
dermal stem cells (holoclones) in the treatment of massive full-
thickness burns with autologous keratinocytes cultured on fibrin.
Transplantation 68:868–879
15. Orive G, Hernandez R, Gascon A, Igarta M, Pedraz J (2002)
Encapsulated cell technology: from research to market. Trends
Biotechnol 20:382–387
16. Glicklis R, Merchuk J, Cohen S (2004) Modeling mass transfer in
hepatocyte spheroids via cell viability, spheroid size, and hepa-
tocellular functions. Biotech Bioeng 86:672–680
17. Obradovic B, Meldon JH, Freed LE, Vunjak-Novakovic G (2000)
Glycosaminoglycan deposition in engineered cartilage: experi-
ments and mathematical model. AIChE J 46:1860–1871
18. Kim S, Yu S, Son J, Huebner H, Buchholz R (1998) Calculations on
O2 transfer in capsules with animal cell for the determination of
maximum capsule size without O2 limitation. Biotechnol Lett
20:549–552
19. Tokuda Y, Crane S, Yamaguchi Y, Zhou L, Falanga V (2000) The
levels and kinetics of oxygen tension detectable at the surface of
human dermal fibroblast cultures. J Cell Physiol 182:414–420
20. Zhao F, Pathi P, Grayson W, Xing Q, Locke BR, Ma T (2005)
Effects of oxygen transport on 3-D human mesenchymal stem
cell metabolic activity in perfusion and static cultures: experi-
ments and mathematical models. Biotechnol Prog 21:1269–1280
21. Ma T, Yang ST, Kniss D (2001) Oxygen tension influences
proliferation and differentiation in a tissue-engineered model of
placental trophoblast-like cells. Tissue Eng 7:495–506
22. Falanga V, Zhou L, Yufit T (2002) Low oxygen tension stimu-
lates collagen synthesis and COL1A1 transcription through the
action of TGF-beta1. J Cell Physiol 191:42–50
23. Malda J, Van Den Brink P, Meeuwse P, Grojec M, Martens DE,
Tramper J, Riesle J, Van Blitterswijk CA (2004) Effect of oxygen
tension on adult articular chondrocytes in microcarrier bioreactor
culture. Tissue Eng 10:987–994
24. Kino-Oka M, Agatahama Y, Haga Y, Inoie M, Taya M (2005)
Long-term subculture of human keratinocytes under an anoxic
condition. J Biosci Bioeng 100:119–122
25. Karel S, Libicki S, Robertson C (1985) The immobilization of
whole cells: Engineering principles. Chem Eng Sci 40:1321–
1354
26. Hager B, Bickenbach JR, Fleckman P (1999) Long-term culture
of murine epidermal keratinocytes. J Invest Dermatol 112:971–
976
27. Bettermann A, Kage A, Salomon A, Schneider, C, Hubner H,
Buchholz R (1999) Cultivation of human skin cells in fibrin
microcapsules. Second international congress: current concept in
pediatric burn care, Florence
28. Jorjani P, Ozturk S (1999) Effects of cell density and temperature
on oxygen consumption rate for different mammalian cell lines.
Biotech Bioeng 64:349–356
29. Denizot F, Lang R (1986) Rapid colorimetric assay for cell
growth and survival. Modifications to the tetrazolium dye pro-
cedure giving improved sensitivity and reliability. J Immunol
Meth 89:271–277
30. Liu H, Mao J, Yao K, Yang G, Cui L, Cao Y (2004) A study on a
chitosan gelatine hyaluronic acid scaffold as artificial skin in vitro
and its tissue engineering applications. J Biomater Sci Polym Ed
15:25–40
31. Muschler G, Nakamoto C, Griffith L (2004) Engineering princi-
ples of clinical cell-based tissue engineering. J Bone Joint Surg
Am 86-A:1541–1558
32. Haselgrove J, Shapiro I, Silverton S (1993) Computer modeling
of the oxygen supply and demand of cells of the avian growth
cartilage. Am J Physiol 265:C497–C506
33. Weinstein G, Mccullough J, Ross P (1985) Cell kinetics basis or
pathophysiology of psoriasis. J Invest Dermatol 85:579–583
34. Treybal R (1980) Mass transfer operations, 2nd edn. McGraw-
Hill, New York
35. Hansen L, Hsiao C, Friend J, Wu F, Bridge G, Remmel R, Cerra F,
Hu W (1998) Enhanced morphology and function in hepatocyte
spheroids: a model of tissue self-assembly. Tissue Eng 4:65–74
36. Kremer M, Lang E, Berger AC (2000) Evaluation of dermal-
epidermal skin equivalents (composite-skin) of human
350 Bioprocess Biosyst Eng (2009) 32:341–351
123
keratinocytes in a collagen-glycosaminoglycan matrix (Integra
artificial skin). Br J Plast Surg 53:459–465
37. Casasco A, Casasco M, Zerbinati N, Icaro Cornaglia A, Calligaro
A (2001) Cell proliferation and differentiation in a model of
human skin equivalent. Anat Rec 264:261–272
38. Weiss E, Yamaguchi Y, Falabella A, Crane S, Tokuda Y, Falanga
V (1998) Un-cross-linked fibrin substrates inhibit keratinocyte
spreading and replication: Correction with fibronectin and factor
XIII cross-linking. J Cell Physiol 174:58–65
39. Ronfard V, Broly H, Mitchell V, Galizia JP, Hochart D, Cham-
bon E, Pellerin P, Huart JJ (1991) Use of human keratinocytes
cultured on fibrin glue in the treatment of burn wounds. Burns
17:181–184
40. Xu W, Li H, Brodniewicz T, Auger FA, Germain L (1996)
Cultured epidermal sheet grafting with Hemaseel HMN fibrin
sealant on nude mice. Burns 22:191–196
41. Renshaw E (1991) Modelling biological populations in space and
time. Cambridge University Press, Cambridge
42. Guarino R, Dike L, Haq T, Rowley J, Pitner J, Timmins M (2004)
Method for determining oxygen consumption rates of static cul-
tures from microplate measurements of pericellular dissolved
oxygen concentration. Biotech Bioeng 86:775–787
Bioprocess Biosyst Eng (2009) 32:341–351 351
123